Smart Cell Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT07030907
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 16, 2025
Completion: May 15, 2030
Loading map...